NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bone Loss



Thrombospondin-2 loss modeled, effect on ovariectomy-induced bone loss revealed



October 6th, 2005

According to recent research from the United States published in the journal Matrix Biology, increased osteoblastogenesis and decreased bone resorption protect against ovariectomy (OVX)-induced bone loss in thrombospondin-2 (TSP-2)-null mice.

"Although bone is composed primarily of extracellular matrix (ECM), the dynamic role that the ECM plays in regulating bone remodeling secondary to estrogen loss is relatively unexplored.

"Previous studies have shown that mice deficient in the matricellular protein TSP2 form excess endocortical bone; thus, we postulated that enhanced bone formation in TSP2-null mice could protect against OVX-induced bone...


Source: Women's Health Weekly (2005-10-06)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login